- Exchange: Tel Aviv
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Teva Pharmaceutical Industries Ltd
Add to PortfolioTEVA:IT
14,900.00 ILs 0.000.00%As of 09:26:45 ET on 05/29/2012.
Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)
| Open: | 15,000.00 | Day's Range: | 14,730.00 - 15,000.00 | Volume: | 312,810 | Bid: | 14,900.00 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 14,900.00 | 52wk Range: | 12,980.00 - 17,590.00 | 1-Yr Rtn: | -12.13% | Ask: | 14,910.00 |
Stock Chart for TEVA
No chart data available.
- TEVA:IT 14,900.00
- 1D
- 1M
- 1Y
14,900.00
…
Previous Close
Key Statistics for TEVA
| Current P/E Ratio (ttm) | 11.9128 |
|---|---|
| Estimated P/E (12/2012) | 7.0631 |
| Earnings Per Share (USD) (ttm) | 3.2278 |
| Est. EPS (USD) (12/2012) | 5.4440 |
| Est. PEG Ratio | 0.7265 |
| Market Cap (M ILS) | 140,477.84 |
| Shares Outstanding (M) | 942.80 |
| Enterprise Value (M USD) (ttm) | 49,330.41 |
| Enterprise Value/EBITDA (ttm) | 9.71 |
| Price/Book (mrq) | 1.5720 |
| Price/Sale (ttm) | 1.7606 |
| Dividend Indicated Gross Yield | 2.6846 |
| Next Earnings Announcement | 07/26/2012 |
More TEVA Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for TEVA
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for TEVA
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
| Phillip FrostChairman | Moshe ManyVice Chairman |
| Jeremy M LevinPresident/CEO | Eyal DeshehChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page